Mesothelioma is a rare type of cancer, most often caused by exposure to asbestos, according to the U.S. Centers for Disease ...

The Mesothelioma Center at Asbestos.com proudly welcomes Dr. Catherine Perrault, D.O., a seasoned family physician and U.S. Navy veteran, to its Patient Advocate team. Dr. Perrault brings her ...

Mesothelioma early symptoms include fluid buildup and difficulty breathing. Learn how to recognize the early signs of mesothelioma.

Prasad Adusumilli and colleagues have shown that CAR T cells that start to lose power can be revived by immunotherapy drugs given several weeks later. Mesothelioma is a rare cancer that affects the ...

WASHINGTON – People with operable diffuse pleural mesothelioma may benefit from immunotherapy before and after surgery, based on results of a clinical trial exploring the sequence of treatment and the ...

The Mesothelioma Victims Center says, "The last thing we want to see is a former power plant or industrial worker who has been diagnosed with mesothelioma cancer lose out on compensation, or get ...

For generations, exposure to asbestos was a silent, hidden danger for millions who served in the U.S. military. The toxic mineral, once valued for its strength and ability to resist heat, was ...

Dr. Hedy Kindler joins us on the podcast to discuss the latest update to the treatment of pleural mesothelioma guideline. She discusses the latest changes to the updated recommendations across topics ...

Mesothelioma symptoms near death worsen as the cancer spreads and organs fail. Learn about the final stages of mesothelioma and how it kills.

A new statistical model may help predict which patients are most likely to receive life-extending benefits from surgical treatment for malignant pleural mesothelioma (MPM), according to an article in ...

HONOLULU (Island News) -- University of Hawaii Cancer Center researchers have secured a $2.5 million National Cancer Institute grant to advance mesothelioma research by improving diagnosis and ...

AUSTIN, Texas, April 28, 2025 /PRNewswire/ -- Genprex, Inc. (GNPX) ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for ...